Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding:: a report by the Israeli Multidisciplinary rFVIIa task

被引：4
|
作者：
Ariëns, RAS [1 ]
机构：
[1] Univ Leeds, LIGHT, Acad Mol Vasc Med, Leeds LS2 9JT, W Yorkshire, England
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2005年 / 3卷 / 04期
关键词：
D O I：
10.1111/j.1538-7836.2005.01263.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：649 / 650
页数：2
相关论文
共 50 条
  • [21] Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage
    Aggarwal A.
    Malkovska V.
    Catlett J.P.
    Alcorn K.
    Thrombosis Journal, 2 (1)
  • [22] Control of a persistent obstetric haemorrhage with activated recombinant factor VII (rFVIIA)
    Jakobsen, DJ
    Shemesh, IY
    Boksenbojm, PM
    Blumenntal, R
    Segal, S
    Yoffe, B
    Martinovitz, U
    INTENSIVE CARE MEDICINE, 2001, 27 : S173 - S173
  • [23] Recombinant activated factor VII (rFVIIa): Characterization, manufacturing, and clinical development
    Jurlander, B
    Thim, L
    Klausen, NK
    Persson, E
    Kjalke, M
    Rexen, P
    Jorgensen, TB
    Ostergaard, PB
    Erhardtsen, E
    Bjorn, SE
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2001, 27 (04): : 373 - 383
  • [24] Recombinant activated factor VII (rFVIIa) in the treatment of 13 patients with severe and active bleeding esophageal varices
    Romero-Castro, R
    Pellicer-Bautista, F
    Jimenez-Saenz, M
    Gomez-Parra, M
    Sendon-Perez, A
    Guerrero-Aznar, MD
    Herrerias-Gutierrez, JM
    GASTROENTEROLOGY, 2004, 126 (04) : A386 - A386
  • [25] Recombinant activated factor VII (rFVIIa) in the treatment of seven cases of severe and active bleeding esophageal varices
    Romero, R
    Pellicer, F
    Jimenez, M
    Gomez, M
    Guerrero, MD
    Sendon, A
    Herrerias, JM
    GASTROINTESTINAL ENDOSCOPY, 2003, 57 (05) : AB143 - AB143
  • [26] Recombinant activated clotting factor VII (rFVIIa) in the treatment of surgical and spontaneous bleeding episodes in hemophilic patients
    Ng, Heng Joo
    Lee, Lai Heng
    VASCULAR HEALTH AND RISK MANAGEMENT, 2006, 2 (04) : 433 - 440
  • [27] Use of recombinant activated factor VII (rFVIIa) in two children with idiopathic thombocytopenic purpura (ITP).
    Minniti, C
    Weinthal, J
    BLOOD, 2001, 98 (11) : 62B - 62B
  • [28] Donor variation in the interaction of activated recombinant factor VII (rFVIIa) with human platelets and detection of a high rFVIIa binding subpopulation
    Koehn, Jadranka
    Boehm, Ernst
    Sedivy, Andrea
    Dockal, Michael
    Scheiflinger, Friedrich
    HAEMOPHILIA, 2014, 20 : 21 - 21
  • [29] Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven®) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery
    Al Douri, M
    Shafi, T
    Al Khudairi, D
    Al Bokhari, E
    Black, L
    Akinwale, N
    Musa, MO
    Al Homaidhi, A
    Al Fagih, M
    Andreasen, RB
    BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 : S121 - S127
  • [30] Clinical scoring systems to guide the use of recombinant activated factor VII (rFVIIa) in major haemorrhage
    Biss, TT
    Hanley, JP
    VOX SANGUINIS, 2006, 90 (04) : 332 - 332
12345